[go: up one dir, main page]

EP1648396A2 - Product for epidermal protection - Google Patents

Product for epidermal protection

Info

Publication number
EP1648396A2
EP1648396A2 EP04742820A EP04742820A EP1648396A2 EP 1648396 A2 EP1648396 A2 EP 1648396A2 EP 04742820 A EP04742820 A EP 04742820A EP 04742820 A EP04742820 A EP 04742820A EP 1648396 A2 EP1648396 A2 EP 1648396A2
Authority
EP
European Patent Office
Prior art keywords
product
fenugreek
epidermis
protective product
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP04742820A
Other languages
German (de)
French (fr)
Inventor
Maité BRUNEAUD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ninapharm (sarl)
Original Assignee
Ninapharm (sarl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ninapharm (sarl) filed Critical Ninapharm (sarl)
Publication of EP1648396A2 publication Critical patent/EP1648396A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Definitions

  • the present invention relates to a product for protecting the epidermis. It relates more particularly to a product allowing reinforced protection of the epidermis, which is based on the association of Nano Active Receptors (NAR) derived from Fenugreek
  • the present invention provides a new product, intended to be used for nutraceutical and cosmetic applications, which allows enhanced protection of the epidermis.
  • the active ingredient is isolated in a membrane composed of bioactive ingredients which provide the guiding role for the release of the active agents on a given target.
  • the product uses the same molecular structure as Fenugreek to release its active ingredients.
  • Fenugreek is made up of Nano-Receptive Receptacles that Engineers have isolated. Said product therefore makes it possible to release the active agents on a given target with great precision and increased efficiency, identical to the molecular structure of Fenugreek.
  • the Fenugreek Isolated Receiver Nanos are incorporated into the lipid membrane, as illustrated in Figure 1, on which we find inside the microcapsule (1), the active (2) and the nano active receptors isolated from Fenugreek (3) in the membrane.
  • the invention thus used protects the activity of the active ingredients and allows their release on the areas hitherto never reached by conventional active ingredients.
  • the product is composed of hollow microspheres formed of lipid bilayers whose membrane is made up of phospholipids and bioactive ingredients: NARs (Nano Active Receptors) from Fenugreek.
  • NARs Nano Active Receptors
  • the characteristics of the liposomes of the invention can be modified.
  • its composition and its size are modified.
  • the affinity of the product is increased by modifying its composition, its electrical charge or by adding receptors or adhesion factors.
  • the product of the invention protects the skin from the inside and from the outside (nutraceutical and cosmetic application).
  • the vitamin and mineral intake decreases and leads to oxidation.
  • the skin needs external and internal intakes of vitamins, fatty acids and antioxidants.
  • the invention makes it possible to penetrate the different layers of the epidermis and to repair lesions with precision.
  • Skin lesions are treated and the skin is rejuvenated from the inside and outside.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a product for epidermal protection, characterised in being obtained from the plant known as Fenugreek.

Description

PRODUIT DESTINE A LA PROTECTION DE L'EPIDERMEPRODUCT FOR THE PROTECTION OF THE SKIN
La présente invention concerne un produit de protection de l'épiderme. Il concerne plus particulièrement un produit permettant une protection renforcée de l'épiderme, qui est basé sur l'association de Nano Actifs Récepteurs (NAR) issus du FenugrecThe present invention relates to a product for protecting the epidermis. It relates more particularly to a product allowing reinforced protection of the epidermis, which is based on the association of Nano Active Receptors (NAR) derived from Fenugreek
Les populations sont de plus en plus à l'écoute de leur corps, et désirent de plus en plus retarder les effets du temps. Aussi les scientifiques sont sans cesse en quête de nouveaux produits. Mais les produits actuellement commercialisés, bien que très développés ne sont pas totalement satisfaisants.People are listening more and more to their bodies, and increasingly want to delay the effects of time. Also scientists are constantly looking for new products. However, the products currently on the market, although very developed, are not entirely satisfactory.
La présente invention propose un nouveau produit, destinée à être utilisée pour des applications nutraceutiques et cosmétiques, qui permet une protection renforcée de l'épiderme.The present invention provides a new product, intended to be used for nutraceutical and cosmetic applications, which allows enhanced protection of the epidermis.
Son principe, consiste à rendre le système de délivrance des actifs plus ciblé, efficace et intelligent, ce qui permet de protéger les actifs contre les agents extérieurs, d'améliorer leurs performances, d'augmenter leur durée de vie ou de conservation, et de différer leurs actions.Its principle consists in making the asset delivery system more targeted, efficient and intelligent, which makes it possible to protect assets against external agents, improve their performance, increase their lifespan or conservation, and defer their actions.
Les scientifiques connaissent les propriétés antidiabétiques de la plante appelée « Fenugrec » et, en tentant de découvrir le mécanisme de l'activité anti-diabétique de cette plante, le déposant s'est aperçu que la « Fenugrec » présentait un système exceptionnel de délivrance de molécules. Lors de ces recherches, il a été mis en évidence que cette plante avait la propriété de faciliter et de guider la circulation des molécules pour agir sur des points précis des couches de l'épiderme et des cellules. Selon l'invention, l'actif est isolé dans une membrane composée d'ingrédients bio-actifs qui assurent le rôle de guidage pour la libération des actifs sur une cible donnée.Scientists know the anti-diabetic properties of the plant called "Fenugreek" and, while trying to discover the mechanism of the anti-diabetic activity of this plant, the applicant has noticed that "Fenugreek" presented an exceptional system of delivery of molecules. During this research, it was revealed that this plant had the property of facilitating and guiding the circulation of molecules to act on specific points in the layers of the epidermis and cells. According to the invention, the active ingredient is isolated in a membrane composed of bioactive ingredients which provide the guiding role for the release of the active agents on a given target.
Selon une caractéristique complémentaire de l'invention, le produit utilise la même structure moléculaire que le Fenugrec pour libérer ses actifs. Le Fenugrec est constitué des Nano- Actifs Récepteurs que les Scientifiques ont isolés. Ledit produit permet donc de libérer les actifs sur une cible donnée avec une grande précision et une efficacité accrue, à l'identique de la structure moléculaire du Fenugrec.According to a complementary characteristic of the invention, the product uses the same molecular structure as Fenugreek to release its active ingredients. Fenugreek is made up of Nano-Receptive Receptacles that Scientists have isolated. Said product therefore makes it possible to release the active agents on a given target with great precision and increased efficiency, identical to the molecular structure of Fenugreek.
Les Nanos Actifs Récepteurs isolés du Fenugrec sont incorporés dans la membrane lipidique, tel que cela est illustré à la figure 1, sur laquelle on trouve à l'intérieur de la micro capsule (1), les actifs (2) et les nano actifs récepteurs isolés du Fenugrec (3) dans la membrane.The Fenugreek Isolated Receiver Nanos are incorporated into the lipid membrane, as illustrated in Figure 1, on which we find inside the microcapsule (1), the active (2) and the nano active receptors isolated from Fenugreek (3) in the membrane.
L'invention ainsi utilisée protège l'activité des ingrédients actifs et permet leur libération sur les zones jusqu'à maintenant jamais atteintes par des actifs classiques.The invention thus used protects the activity of the active ingredients and allows their release on the areas hitherto never reached by conventional active ingredients.
Il y a ainsi :There are thus:
- protection de phase active,- active phase protection,
- isolation d'actif,- asset isolation,
- libération contrôlée d'actif.- controlled release of assets.
Les avantages du produit selon l'invention sont :The advantages of the product according to the invention are:
- une libération prolongée,- prolonged release,
- une libération au bon moment, au bon endroit, - l'inoculation de petites quantités, donc pas de problème de toxicité,- release at the right time, in the right place, - inoculation of small quantities, so no toxicity problem,
- une durée de vie accrue,- an increased lifespan,
- une protection contre la lumière, l'oxygène, les réactions parasites,- protection against light, oxygen, parasitic reactions,
- une concentration élevée en principes actifs,- a high concentration of active ingredients,
- pas d'ingrédient d'origine animale, seulement des ingrédients d'origine végétale.- no ingredient of animal origin, only ingredients of vegetable origin.
Selon l'invention, le produit (liposome) est composé de micro- sphères creuses formées de bicouches de lipides dont la membrane est constituée par des phospholipides et des ingrédients bio-actifs : NARs (Nano Actif Récepteurs) issus du Fenugrec.According to the invention, the product (liposome) is composed of hollow microspheres formed of lipid bilayers whose membrane is made up of phospholipids and bioactive ingredients: NARs (Nano Active Receptors) from Fenugreek.
Selon les besoins, les caractéristiques des liposomes de l'invention peuvent être modifiées. Pour diminuer la vitesse de dégradation du produit et ralentir la libération de son contenu, on modifie sa composition et sa taille.As required, the characteristics of the liposomes of the invention can be modified. To reduce the rate of degradation of the product and slow the release of its content, its composition and its size are modified.
Pour augmenter la concentration de l'actif sur la cible, on augmente l'affinité du produit en modifiant sa composition, sa charge électrique ou en ajoutant des récepteurs ou des facteurs d'adhérence.To increase the concentration of the active ingredient on the target, the affinity of the product is increased by modifying its composition, its electrical charge or by adding receptors or adhesion factors.
Le produit de l'invention protège la peau de l'intérieur et de l'extérieur (application nutraceutiques et cosmétiques).The product of the invention protects the skin from the inside and from the outside (nutraceutical and cosmetic application).
Lorsque la peau vieillie, les apports en vitamines, minéraux diminuent et entraînent l'oxydation. La peau a besoin d'apports extérieurs et intérieurs en vitamines, acides gras et antioxydants. En effet, l'invention permet de pénétrer les différentes couches de l'épiderme et de réparer les lésions avec précision.When the skin ages, the vitamin and mineral intake decreases and leads to oxidation. The skin needs external and internal intakes of vitamins, fatty acids and antioxidants. In fact, the invention makes it possible to penetrate the different layers of the epidermis and to repair lesions with precision.
Lorsque le produit est ingéré oralement, ses nanoparticules circulent à travers les vaisseaux sanguins pour finir par pénétrer les différentes couches de l'épiderme.When the product is ingested orally, its nanoparticles circulate through the blood vessels to eventually penetrate the different layers of the epidermis.
Les lésions de la peau sont soignées et la peau est rajeunie de l'intérieur comme de l'extérieur.Skin lesions are treated and the skin is rejuvenated from the inside and outside.
Le produit selon l'invention trouve son application en :The product according to the invention finds its application in:
complément alimentaire anti-âge,anti-aging food supplement,
- complément alimentaire anti-oxydant beauté,- antioxidant beauty food supplement,
- sérum pour stimuler les cellules de la peau et leurs r égénérescences .- serum to stimulate skin cells and their regeneration.
Bien entendu, l'invention n'est pas limitée aux modes de réalisation décrits et représentés à titre d'exemples, mais elle comprend aussi tous les équivalents techniques ainsi que leurs combinaisons. Of course, the invention is not limited to the embodiments described and shown by way of examples, but it also includes all the technical equivalents and their combinations.

Claims

REVENDICATIONS
1- Produit de protection pour l'épiderme caractérisé en ce qu'il est obtenu à base de la plante appelée Fenugrec.1- Protective product for the epidermis, characterized in that it is obtained from the plant called Fenugreek.
2- Produit de protection pour l'épiderme selon la revendication 1, caractérisé en ce qu'il est obtenu par l'association de Nano Actifs Récepteurs (NAR) issus du Fenugrec.2- Protective product for the epidermis according to claim 1, characterized in that it is obtained by the association of Nano Receptive Actives (NAR) from Fenugreek.
3- Produit de protection pour l'épiderme selon la revendication 2, caractérisé en ce que le produit est composé de micro-sphères creuses formées de bicouches de lipides dont la membrane est constituée par des phospholipides et des ingrédients bio-actifs (NARs Nano Actifs Récepteurs), issus du Fenugrec.3- Protective product for the epidermis according to claim 2, characterized in that the product is composed of hollow micro-spheres formed of lipid bilayers whose membrane is made up of phospholipids and bioactive ingredients (NARs Nano Active Receivers), from Fenugreek.
4- Produit de protection pour l'épiderme selon l'une quelconque des revendications précédentes, caractérisé en ce qu'il est constitué de micro capsules (1) comprenant les actifs (2) et dont la membrane (3) comprend les nano actifs récepteurs isolés du Fenugrec.4- Protective product for the epidermis according to any one of the preceding claims, characterized in that it consists of micro capsules (1) comprising the active agents (2) and whose membrane (3) comprises the nano active receptors isolated from Fenugreek.
5- Produit de protection pour l'épiderme selon l'une quelconque des revendications, caractérisé en ce qu'il est destiné à être utilisé pour des applications nutraceutiques et cosmétiques.5- Protective product for the epidermis according to any one of claims, characterized in that it is intended to be used for nutraceutical and cosmetic applications.
6- Procédé d'obtention du produit de protection selon l'une quelconque des revendications précédentes, caractérisé en ce qu'il consiste à isoler l'actif dans une membrane composée d'ingrédients bio-actifs pour assurer le rôle de guidage pour la libération des actifs sur une cible donnée. 6- A method for obtaining the protective product according to any one of the preceding claims, characterized in that it consists in isolating the active ingredient in a membrane composed of bioactive ingredients for provide the guiding role for the release of the active agents on a given target.
EP04742820A 2003-05-23 2004-05-22 Product for epidermal protection Ceased EP1648396A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0306552 2003-05-23
PCT/FR2004/001282 WO2004105719A2 (en) 2003-05-23 2004-05-22 Product for epidermal protection

Publications (1)

Publication Number Publication Date
EP1648396A2 true EP1648396A2 (en) 2006-04-26

Family

ID=33484286

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04742820A Ceased EP1648396A2 (en) 2003-05-23 2004-05-22 Product for epidermal protection

Country Status (2)

Country Link
EP (1) EP1648396A2 (en)
WO (1) WO2004105719A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3031669B1 (en) * 2015-01-19 2020-01-31 Ninapharm ADVANCED DELIVERY SYSTEM (ADS)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196190A (en) * 1990-10-03 1993-03-23 Zenith Technology Corporation, Limited Synthetic skin substitutes
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
IL122776A (en) * 1997-12-28 2004-07-25 Dead Sea Lab Ltd Gel composition for skin care and protection and a method for preparation thereof
EP1216065B1 (en) * 1999-10-01 2008-10-29 Acrymed Silver-containing compositions, devices and methods for making
FR2803513B1 (en) * 2000-01-12 2003-12-19 Oreal USE OF DHEA AND / OR ITS PRECURSORS OR DERIVATIVES TO IMPROVE THE PAPYRACE OF THE SKIN
FR2827765B1 (en) * 2001-07-27 2003-09-19 Oreal COMPOSITION BASED ON LIPID LAMELLAR VESICLES INCORPORATING AT LEAST ONE DHEA-BASED COMPOUND

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004105719A2 *

Also Published As

Publication number Publication date
WO2004105719A3 (en) 2005-04-07
WO2004105719A2 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
EP1443898B1 (en) Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells
CA2616443C (en) Uses of sporopollenin as an antioxidant
US20130309298A1 (en) Formulations comprising exine shells
TW200908891A (en) Microencapsulating compositions, methods of making, methods of using and products thereof
EP2911680B1 (en) Use of a flax extract, originating from the hydrolysis of flax proteins, as an active antimicrobial agent
Fang et al. Facile biofilm penetration of cationic liposomes loaded with DNase I/Proteinase K to eradicate Cutibacterium acnes for treating cutaneous and catheter infections
EP2293783B1 (en) Whitened exine shells
EP1648396A2 (en) Product for epidermal protection
CH664490A5 (en) PROCESS FOR THE PREPARATION OF COSMETIC COMPOSITIONS CONTAINING LYSED EXTRACTS FROM HAFNIA.
EP2419439B1 (en) Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate
FR2556218A1 (en) Pharmaceutical product for local application consisting of the combination of a medicinal active ingredient and an enzymatic agent
EP2055200A1 (en) Batch of food supplements comprising the association of an extract of a plant belonging to the rosaceous family and an extract of sea fennel.
EP1480610B1 (en) Use of a hsp inducing compound to limit secondary effects of retinoids
CA2426284A1 (en) Anti-adiposis composition based on garlic bulb extracts
FR2854072A1 (en) VECTOR FOR ORAL ADMINISTRATION
EP2309981A2 (en) Dermatological composition that can be used in particular for the care and prevention of eschars
FR2850574A1 (en) Regenerating cosmetic composition, useful for treatment of the skin, contains a lipid extract from pearl-bearing molluscs, particularly oysters
FR3015278A1 (en) OILY MACERATE OF PATIRON (CUCURBITA MAXIMA) FOR A COSMETIC USE
FR2832628A1 (en) Product for inducing synthesis of stress protein, useful as food or cosmetic additive e.g. for protection against heat shock, contains extract of red algae
FR3049462A1 (en) USE OF EXTRACTS OF DEINOCOCCUS BACTERIA AS COSMETIC OR PHARMACEUTICAL AGENTS
FR3018685B1 (en) COSMETIC AND PHARMACEUTICAL APPLICATIONS OF SALICARIA
CN116019778A (en) Preparation method of peony pistil composite microcrystal capsule composition and application of peony pistil composite microcrystal capsule composition in resisting blue light, protecting cells, resisting allergy and resisting aging
CN117257675A (en) Cyclic gamma-polyglutamic acid nano microcapsule and preparation method and application thereof
FR3151200A1 (en) METHOD OF APPLYING A NATURAL EXTRACT TO THE SKIN TO CARRY OUT BIOSYNTHESIS OF METABOLITES OF INTEREST AT THE LEVEL OF THE SKIN MICROBIOTA
FR2835745A1 (en) Retinoid containing cosmetic or dermatological composition used e.g. for combating skin aging, contains heat shock protein inducer, preferably Artemisia salina extract

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051214

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20060725

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APAZ Date of receipt of statement of grounds of appeal deleted

Free format text: ORIGINAL CODE: EPIDOSDNOA3E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAV Appeal reference deleted

Free format text: ORIGINAL CODE: EPIDOSDREFNE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20140722